Information About Vaxzevria

Disclaimer: The information on this page is intended for Vaccine Recipients only.

Vaxzevria has been given ‘conditional approval’. This means that there is more evidence to come about this medicine. The European Medicines Agency will review new information on this medicine at least every year and the leaflet will be updated as necessary. During the pandemic, Vaxzevria may also be distributed in packaging with the name COVID‑19 Vaccine AstraZeneca.

You can find more information here (https://www.ema.europa.eu/en).

Please refer to your Healthcare Provider for further information, or you can contact the AstraZeneca Medical Information team here. 

Report an Adverse Event via the Health Products Regulatory Authority website

If you are concerned about an adverse event, it can be reported via the Health Products Regulatory Authority website, (https://www.hpra.ie/homepage/about-us/report-an-issue/covid-19-vaccine-adverse-reaction).

This link will take you to another website. AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.